Boothbay Fund Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1483 |
|
|
2025
Q1 | – | Sell |
-20,188
| Closed | -$779K | – | 1524 |
|
|
2024
Q4 | $779K | Buy |
+20,188
| New | +$779K | 0.02% | 596 |
|
|
2024
Q1 | – | Sell |
-80,607
| Closed | -$1.85M | – | 1666 |
|
|
2023
Q4 | $1.85M | Buy |
+80,607
| New | +$1.85M | 0.05% | 433 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1766 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1943 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2132 |
|
|
2022
Q3 | – | Sell |
-57,923
| Closed | -$458K | – | 2228 |
|
|
2022
Q2 | $458K | Sell |
57,923
-98,718
| -63% | -$781K | 0.01% | 1067 |
|
|
2022
Q1 | $3.71M | Buy |
+156,641
| New | +$3.71M | 0.09% | 256 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1945 |
|
|
2020
Q2 | – | Sell |
-23,039
| Closed | -$163K | – | 965 |
|
|
2020
Q1 | $163K | Buy |
23,039
+10,146
| +79% | +$71.8K | 0.01% | 588 |
|
|
2019
Q4 | $91K | Sell |
12,893
-36,079
| -74% | -$255K | 0.01% | 663 |
|
|
2019
Q3 | $588K | Sell |
48,972
-56,993
| -54% | -$684K | 0.05% | 358 |
|
|
2019
Q2 | $1.28M | Buy |
+105,965
| New | +$1.28M | 0.12% | 166 |
|
|
2019
Q1 | – | Sell |
-19,917
| Closed | -$134K | – | 764 |
|
|
2018
Q4 | $134K | Buy |
+19,917
| New | +$134K | 0.02% | 448 |
|